금융 뉴스 허브

The One Thing Jim Cramer Demands From Tech-Only Investors Before He’ll Bless the Strategy

Jim Cramer just refused to bless a portfolio built almost entirely on his own stock recommendations, and no question that the lesson is worth pausing on. On the May 22 episode of Mad Money, a caller n ...

Ready Capital, Gemini Space Station among financial stocks set to join Russell Microcap; Dave, SelectQuote to exit

Gold rises on U.S.-Iran peace hopes, weaker dollar

Berkshire Hathaway Stock Lags Industry in 3 Months: Is it Still a Buy?

Berkshire Hathaway's insurance float fuels investments as the company shifts to Japan trading houses and builds BHE renewables, backed by $370B+ cash.

US Stock Futures Gain as Crude Oil Drops on Iran: Markets Wrap

(Bloomberg) -- Global stocks rose to record highs as crude oil fell after officials signaled the US was nearing a deal with Iran to reopen the Strait of Hormuz and restore oil flows. The dollar weaken ...

BE Stock Outpaces Its Industry in the Past 6 Months: How to Play?

BE has surged 199% in 6 months as AI data centers fuel demand for its Energy Server, clean power and earnings estimates keep rising.

Oil: WTI and Brent test key psychological levels – Scotiabank

Scotiabank’s Global FX Strategy team highlights that global benchmark Oil prices are lower, with WTI nearing the psychologically important $90/bbl level and Brent slipping toward the mid-$90s after br ...

Sypris Stock Rises 5% Despite Incurring a Wider Y/Y Loss in Q1

SYPR incurs a wider year-over-year net loss per share in Q1'26 as material shortages and manufacturing inefficiencies pressured margins, though defense and energy order growth support a more optimisti ...

Kazakhstan's First Nuclear Plant Faces More Delays

Beset with financing difficulties, Rosatom, Russia’s nuclear energy entity, is begging for more time to start building Kazakhstan’s first nuclear power plant on the shores of Lake Balkhash. The site w ...

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.

Dollar eases as Iran deal optimism and oil swings drive sentiment: Currency Recap

Digital Turbine Q4 2026 Earnings Preview